What is the Connection Between Diabetes and Addiction?

Insulin and Dopamine Regulation Overlap

Insulin, which regulates blood sugar, and dopamine, which influences motivation and reward, operate closely within the brain’s signaling systems. In Ohioans dealing with both diabetes and substance use concerns, disruptions in one of these systems can amplify problems with the other. For example, repeated substance use—such as alcohol or opioids—can make the brain less sensitive to dopamine, while also interfering with insulin’s ability to keep blood glucose stable.

Research shows that this overlap in insulin and dopamine signaling heightens the risk of poor diabetes management, increased cravings, and health complications common to both conditions. When considering the connection between diabetes and addiction, understanding this brain chemistry interaction helps explain why integrated care is so important. The terms insulin resistance and reward circuitry often come up when Ohio clinicians develop local treatment strategies for dual-diagnosis clients.⁴

Delta Opioid Receptors and Blood Sugar

Delta opioid receptors, found throughout the brain and pancreas, are a key piece of the connection between diabetes and addiction. These receptors influence not only pain and mood but also the body’s metabolic processes. New research shows that people with type 2 diabetes have lower expression of the delta opioid receptor (OPRD1) in their pancreatic islets, and blocking this receptor boosts insulin release from beta cells^[5].

This finding means opioid misuse could directly impact blood sugar control, compounding the challenges for Ohioans facing both substance use and diabetes. The overlap between opioid signaling and metabolic homeostasis—how the body keeps blood sugar steady—helps explain why substance use disorders are especially risky for individuals with type 2 diabetes. This perspective is shifting how Buckeye State providers approach integrated care for dual diagnoses.

When Diabetes Increases Substance Use Risk

For Ohioans living with diabetes, the stress of constant blood sugar monitoring, dietary restrictions, and medication schedules can push emotional resilience to its limits. These daily pressures can contribute to feelings of burnout or low mood, which sometimes leads individuals to seek relief through alcohol or other substances. When managing diabetes becomes overwhelming, the risk of turning to substance use as a form of self-medication grows.

Researchers have found that challenges with chronic illness, such as diabetes, are linked to an increased likelihood of developing behavioral health concerns, including substance use disorders. This pattern fits into the broader connection between diabetes and addiction, as both conditions can involve changes to dopamine signaling and self-control, making cravings stronger. Ohio care providers notice that emotional factors—like depression or feeling isolated—frequently heighten this risk.⁸

How Substance Use Accelerates Diabetes

Substance use—whether involving alcohol, opioids, or stimulants—can rapidly worsen diabetes for many Ohioans facing both challenges. Research makes it clear that having an active substance use disorder disrupts blood sugar control, increases insulin resistance, and often leads to inconsistent medication habits or skipping glucose checks. This pattern speeds up diabetes complications, including risks like lower-limb amputation and more frequent hospital admissions compared to living with diabetes alone.^4,8

For example, opioid use can interfere directly with how the pancreas and brain process insulin, further complicating metabolic balance—a key reason the connection between diabetes and addiction matters so deeply in our region. When substance use accelerates diabetes, both psychological and biological pathways get disrupted, contributing to higher hospitalization rates and harder-to-manage blood sugars.

Blood Sugar Monitoring Disruptions

Blood sugar monitoring disruptions are common among Ohioans struggling with both diabetes and substance use concerns. When the connection between diabetes and addiction takes hold, individuals may skip routine glucose checks, misplace test supplies, or feel overwhelmed by the daily demands of diabetes self-care. These missed checks are not just oversights—they make it much harder to keep blood glucose within a healthy range, raising the likelihood of emergency room visits and longer-term complications.

In fact, the presence of substance use disorder is strongly linked to struggles with regular blood sugar testing and poorer overall glycemic control than seen in diabetes alone. The overlapping challenges of addiction and diabetes self-management—such as managing cravings, feeling burned out, or losing focus—are reported by many Buckeye State clinics working with dual-diagnosis clients. If ongoing lapses in monitoring are happening, this could point to a need for integrated care that addresses both health issues together.⁸

Medication Non-Adherence Patterns

Medication non-adherence is a frequent warning sign for Ohioans navigating both diabetes and substance use concerns. The connection between diabetes and addiction often reveals itself through a pattern of missed or forgotten medications—skipping doses of insulin, oral diabetes prescriptions, or neglecting to pick up refills on time. Substance use disorder increases the challenge of keeping up with medical routines, further disrupting metabolic stability and elevating the risk of complications.

Research indicates that individuals managing both conditions are much more likely to fall behind on prescribed treatments than those with diabetes alone, contributing to poor glycemic control and more diabetes-related hospitalizations. Healthcare providers across Ohio note that stress, withdrawal symptoms, and changes in daily rhythm tied to substance use make it harder for individuals to stick to their medication plan. This kind of ongoing medication non-adherence is a hallmark of dual diagnosis.⁸

Mortality and Hospitalization Factors

Mortality and hospitalization risks climb steeply when the connection between diabetes and addiction is present. In Ohio, individuals facing both type 2 diabetes and substance use concerns experience hospital stays and diabetes-related complications at much higher rates than those with only one of these challenges. Research confirms that, among people with both diabetes and opioid use, a staggering 63.8% of all deaths are tied to these combined risk factors—meaning the overlap elevates the odds of a serious health event or early death by more than double compared to non-diabetic, non-opioid users.⁷

Lower-limb amputations, infections, and emergency room visits are also significantly more common among Buckeye State residents with this dual diagnosis. These findings highlight how intertwined metabolic instability, poor self-care, and substance cravings can drive up acute health crises. This path makes sense for Ohioans and their care teams to evaluate whenever hospital visits become more frequent, or recovery from illness or surgery is slow.⁴

HbA1c Control Deterioration Markers

HbA1c, a marker of long-term blood sugar control, often deteriorates when Ohioans are living with both diabetes and substance use disorder. Those dealing with the dual diagnosis frequently see rising HbA1c values, reflecting persistent high blood glucose and lapses in daily management routines. According to recent studies, individuals with untreated substance use disorder are 5.91 times more likely to fail at achieving target HbA1c control than those receiving treatment, underscoring the significant impact this combined challenge has on metabolic health.³

Patterns like HbA1c increases above 8% despite medical intervention, or sharp fluctuations between appointments, are warning signs that the connection between diabetes and addiction is disrupting glycemic stability. Noticing these changes is crucial—especially for Buckeye State residents—because they signal an urgent need for coordinated care and may predict more serious health complications ahead.

Why Simultaneous Treatment Works Better

Simultaneous treatment—addressing both diabetes and substance use together—consistently leads to better outcomes for Ohioans dealing with these intertwined health concerns. By uniting medical and behavioral care, providers can quickly adapt diabetes medications, supervise blood sugar changes, and provide recovery support in real time. Research shows integrated care results in significantly fewer hospitalizations, better glycemic control, and reduced mortality compared to treating each condition separately.⁹

This approach works best when both medical management and substance cravings are disrupting daily life, since clinicians can catch complications early and adjust care on the spot. When diabetes and substance use challenges are tackled through a single plan, individuals often report improved motivation and less stress in following their treatments—both key factors in breaking the cycle of dual diagnosis. The connection between diabetes and addiction makes this integration essential for lasting stability.

Ohio Dual Diagnosis Treatment Options

Ohioans seeking treatment for both diabetes and substance use concerns have a growing range of dual diagnosis options tailored to the connection between diabetes and addiction. Top choices include integrated outpatient programs, intensive inpatient (residential) services, and multidisciplinary clinics, many located in major cities like Columbus, Cleveland, and Cincinnati. These programs blend diabetes care—such as medication adjustments and glucose monitoring—with counseling and recovery therapies delivered by behavioral health specialists.

Facilities like Arrow Passage Recovery offer person-first, coordinated approaches, and many Ohio clinics accept Medicaid or sliding-scale payments, making care more accessible to all residents. Most dual diagnosis programs require a commitment of at least 12 weeks, with sessions two to four times per week, and typical costs range from $350 to $900 per session depending on the level of care. Recent statewide research confirms that these integrated approaches not only improve health outcomes but also lower the risk of hospitalization and diabetes complications for Buckeye State residents.⁹

Buprenorphine-Naloxone for Blood Sugar

Buprenorphine-naloxone, a common medication-assisted treatment for opioid use disorder, offers real benefits for Ohioans managing both substance use struggles and type 2 diabetes. Clinical research has shown that individuals engaged in buprenorphine-naloxone therapy not only experience reduced drug cravings and greater stability in their recovery, but also see a clinically meaningful decrease in HbA1c—a key marker of long-term blood sugar control—averaging a 1.20% absolute reduction over two years.⁶

For those in the Buckeye State wrestling with both conditions, this effect can make diabetes management less overwhelming, supporting better daily routines and less risk for complications. This approach fits best when blood sugar levels are unpredictable and substance use makes sticking to diabetes care tough. The positive metabolic impact reinforces the connection between diabetes and addiction, revealing how addressing opioid dependence with buprenorphine-naloxone leads to stronger glycemic control alongside improved quality of life.

GLP-1 Agonists and Overdose Prevention

GLP-1 agonists, like semaglutide, are a cutting-edge treatment option for Ohioans managing both type 2 diabetes and a history of opioid use. These medications not only support blood sugar control but also have been linked to a reduced risk of opioid overdose, likely by modulating the brain’s reward pathways that drive cravings. In a recent study of over 33,000 adults with both diabetes and opioid use disorder, those prescribed semaglutide showed a 42–68% lower risk of overdose in the following year compared to those on other diabetes treatments.¹

This makes GLP-1 agonists especially valuable for Buckeye State residents at risk for dual relapse or medical complications. This solution fits people seeking dual benefits—improved glycemic control and protection from overdose—within one streamlined therapy as part of an integrated care approach. For effective ongoing care, these medications require close monitoring by both diabetes and behavioral health teams, with costs in Ohio averaging $600–$900 per session, including labs and follow-up visits.

Medical Detoxification Considerations

Medical detoxification is a critical first step for Ohioans experiencing both substance use and diabetes, given the unique medical risks posed by this combination. The connection between diabetes and addiction increases the chance of blood sugar instability during withdrawal—especially when detoxing from opioids, alcohol, or stimulants, which can quickly throw off glucose levels and lead to emergency situations. Providers in Ohio recommend that medical detox for people with diabetes always takes place in a supervised setting where blood glucose and vital signs are continuously monitored.

This strategy suits individuals who have a history of severe withdrawal symptoms, recurrent hypoglycemia, or have previously needed hospitalization during a quit attempt. The typical cost for medically supervised detox ranges from $900 to $2,500 for a three- to five-day stay in Ohio, depending on the program’s level of support and whether specialized endocrinology care is available. Preparation often requires organizing diabetes supplies (such as insulin, monitors, snacks) and informing both the addiction and diabetes care team about medication regimens.

Baseline Health Metrics Documentation

Documenting baseline health metrics is a crucial step for Ohioans starting recovery with both diabetes and substance use challenges. To track progress and guide your team’s strategy, gather key data: current HbA1c (average blood sugar over three months), daily blood glucose logs, blood pressure readings, weight, and a record of medication adherence or missed doses. Documenting these numbers with a logbook, a smartphone app recommended by Ohio clinics, or patient portals can reveal how the connection between diabetes and addiction is affecting your day-to-day stability and help clinicians spot risk patterns early.

LSI keywords like glycemic control and dual diagnosis management are central in this process, as accurate tracking allows your care team to catch even small changes before they become serious setbacks. Recent research shows people who collaborate on tracking and sharing metrics with their providers achieve better diabetes outcomes and a lower likelihood of hospital admission^[3]. For most in Ohio, assembling these records takes 30–45 minutes with support from a nurse or social worker, usually as part of your first assessment.

Selecting Appropriate Treatment Intensity

Choosing the right treatment intensity is an essential decision for Ohioans managing both diabetes and substance use concerns. Use this step-by-step decision tool:

• If you need daily medical monitoring or have experienced severe blood sugar swings, residential (inpatient) care is recommended, offering round-the-clock support and rapid coordination between diabetes and behavioral health teams.
• For those with more stable HbA1c values and a reliable home environment, intensive outpatient (IOP) programs—attended several times per week—may deliver the level of dual diagnosis management needed, blending structure with daily life responsibilities.
• Standard outpatient care suits individuals who show steady progress, have lower relapse risk, and can consistently access both metabolic and behavioral check-ins.

The connection between diabetes and addiction means that integrated recovery planning works best when treatment intensity matches medical risk, cravings, and support at home. Costs in Ohio typically range from $350 per outpatient session to $2,500 for a week of residential care, with time commitments scaling from a few hours per week to full days. Dual diagnosis care models like these continue to show superior health improvements compared to separate or less intensive approaches.⁹

Resource Planning and Insurance Navigation

Resource and insurance navigation is a vital step for Ohioans working through the connection between diabetes and addiction. Start by making a checklist: confirm your treatment program is in-network with your insurance, ask about copayments or sliding-scale options, and explore local aid resources like Buckeye Health or Medicaid for dual diagnosis coverage. This approach works best for families who want clarity on financial responsibilities upfront and less disruption in ongoing dual diagnosis management.

Many providers—such as Arrow Passage Recovery—offer help with paperwork and prior authorizations, which saves time and reduces billing surprises. Costs for case management or insurance navigation usually range from $0 (for Medicaid-eligible) up to $200 depending on program complexity and any specialty referrals required. Integrated recovery planning becomes easier when you utilize Ohio referral networks and support services focused on dual treatment. Studies in the Buckeye State confirm that individuals accessing both medical and behavioral health coverage are more likely to complete integrated care, improving health outcomes related to the connection between diabetes and addiction.⁸